Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?

Journal of Health Economics

Volumn 32, Issue 1, 2013, Pages 268-285

  de Frutos, Maria Angeles ^a   Ornaghi, Carmine ^b   Siotis, Georges ^a,c,d  

^a UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c EUROPEAN COMMISSION   (Belgium)

^d CEPR   (United Kingdom)

Author keywords

Advertising; Market segmentation; Pharmaceutical industry; Product differentiation

Indexed keywords

ADVERTISING; COMPETITION (ECONOMICS); EMPIRICAL ANALYSIS; NUMERICAL MODEL; PHARMACEUTICAL INDUSTRY; QUALITATIVE ANALYSIS;

ARTICLE; COMPETITION; CONSUMER HEALTH INFORMATION; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; DRUG QUALITY; MATHEMATICAL MODEL; PRESCRIPTION; STRATEGIC PLANNING;

ADVERTISING AS TOPIC; DRUG INDUSTRY; ECONOMIC COMPETITION; HUMANS; MODELS, ECONOMIC; PHARMACEUTICAL PREPARATIONS;

EID: 84870841770     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2012.07.006     Document Type: Article

References (31)

1. Azoulay P. Do pharmaceutical sales respond to scientific evidence?. Journal of Economics and Management Strategy 2002, 11(4):551-594.
2. Bagwell, K., 2007. The Economic Analysis of Advertising. Handbook of Industrial Organization, vol. 3. North-Holland: Amsterdam, 1701-1844.
3. Bala R., Bhardwaj P. Detailing vs. direct-to-consumer advertising in the prescription pharmaceutical industry. Management Science 2010, 56:148-160.
4. Barfett J., Lanting B., Lee J., Lee M., Ng V., Simkhovitch P. Pharmaceutical marketing to medical students: the student perspective. McGill Journal of Medicine 2004, 8:21-27.
5. Baye M.R., Morgan J. Brand and price advertising in online markets. Management Sciences 2009, 55:1139-1151.
6. Brekke K., Kuhn M. Direct to consumer advertising in pharmaceutical markets. Journal of Health Economics 2006, 5(1):102-130.
7. Chioveanu I. Advertising brand loyalty and pricing. Games and Economic Behavior 2008, 64(1):68-80.
8. Christou C., Vettas N. On informative advertising and product differentiation. International Journal of Industrial Organization 2008, 26:92-112.
9. Dave, D., Saffer, H., 2010. The impact of Direct-to-Consumer advertising on pharmaceutical prices and demand. NBER Working Paper 15696.
10. De Frutos, M.A., Ornaghi C., Siotis, G., 2010. How do brand producers react to generic entry? MIMEO.
11. von der Fehr N.-H., Stevin K. Persuasive advertising and product differentiation. Southern Economic Journal 1998, 65:113-126.
12. Frank, R.G., Salkever, D.S., 1992. Pricing, patent loss and the market for pharmaceuticals. Southern Economic Journal 59(2), 165-179.
13. Ganuza, J.J., Llobet, G., Dominguez, B., 2009. R&D in the pharmaceutical industry: a world of small innovations. Management Science 55(4), 539-551.
14. Grossman G., Shapiro S. Informative advertising with differentiated products. Review of Economic Studies 1984, 51:63-81.
15. Hollon M. Direct-to-Consumer advertising: a hazard approach to health promotion. Journal of American Medical Association 2005, 293(16):2030-2033.
16. Iizuka T. What explains the use of Direct-to-Consumer advertising of prescription drugs?. Journal of Industrial Economics 2004, 52(3):349-379.
17. Iizuka T., Jin G. Direct-to-Consumer advertising and prescription choice. Journal of Industrial Economics 2007, 55(4):771.
18. Johnson J., Myatt D. On the simple economics of advertising, marketing and product design. American Economic Review 2006, 96:756-784.
19. Klette T.J. Market power, scale economies and productivity: estimates from a panel of establishment data. The Journal of Industrial Economics 1999, 48:451-476.
20. Konigbauer I. Advertising and generic market entry. Journal of Health Economics 2007, 6(2):286-305.
21. Linnosmaa, I.E., 2008. Advertising, free-riding, and price differences in the market for prescription drugs. The B.E. Journal of Economic Analysis & Policy 8(2), article 8.
22. Lu Z.J., Comanor C.S. Strategic pricing of new pharmaceuticals. The Review of Economic and Statistics 1998, 80:108-118.
23. Mayerhoefer, C.D., Zuvekas, S.H., 2008. The shape of demand; what does it tell us about direct-to-consumer marketing of antidepressant. The B.E. Journal of Economic Analysis and Policy 8(2), article 4.
24. Moulton B. An illustration of a pitfall in estimating the effects of aggregate variables on micro unit. Review of Economics and Statistics 1990, 72:334-338.
25. Regan T.L. Generic entry, price competition, and market segmentation in the prescription drug market. International Journal of Industrial Organization 2008, 26:930-948.
26. Rizzo J.A. Advertising and competition in the ethical pharmaceutical industry: the case of antihypertensive drugs. Journal of Law and Economics 1999, 42:89-116.
27. Tullock G. The welfare cost of tariffs, monopolies, and theft. Western Economic Journal 1967, 5:224-232.
28. Vives X. Nash equilibrium with strategic complementarities. Journal of Mathematical Economics 1990, 19:305-321.
29. Vives X. Complementarities and games: new developments. Journal of Economic Literature 2006, 43:437-479.
30. Wooldridge J.M. Econometric Analysis of Cross Section and Panel Data 2001, The MIT Press, Cambridge, Massachusetts.
31. Wosinska, M., 2002. Just what the patient ordered? Direct-to-Consumer advertising and the demand for pharmaceutical products (October 2002). HBS Marketing Research Paper No. 02-04. Available at SSRN: http://ssrn.com/abstract=347005.